Article info
PDFOriginal research
BCL2 and BCL6 atypical/unbalanced gene rearrangements in diffuse large B-cell lymphoma are indicators of an aggressive clinical course
- Correspondence to Dr Vanessa Lacheretz-Szablewski, CHU Montpellier, Montpellier 34295, France; vszmed{at}hotmail.fr
Citation
BCL2 and BCL6 atypical/unbalanced gene rearrangements in diffuse large B-cell lymphoma are indicators of an aggressive clinical course
Publication history
- Received May 18, 2020
- Revised July 8, 2020
- Accepted August 10, 2020
- First published September 10, 2020.
Online issue publication
January 09, 2022
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.